Gilead Sciences Inc (WBO:GILD)
€ 80.18 -0.54 (-0.67%) Market Cap: 99.70 Bil Enterprise Value: 118.71 Bil PE Ratio: 105.76 PB Ratio: 5.91 GF Score: 78/100

Q2 2024 Gilead Sciences Inc Earnings Call Transcript

Aug 08, 2024 / 08:30PM GMT
Release Date Price: €68.99 (+0.50%)
Operator

Good afternoon, everyone, and welcome to Gilead's second-quarter 2024 earnings conference call. My name is Rebekah, and I'll be your host for today. (Operator Instructions)

I'll now hand the call over to Jacquie Ross, Vice President of Investor Relations and Corporate Strategic Finance.

Jacquie Ross
Gilead Sciences Inc - Vice President, Investor Relations & Corporate Strategic Finance.

Thank you, Rebekah. Just after market close today, we issued a press release with earnings results for the second quarter of 2024. The press release, slides, and supplementary data are available on the Investors section of our website at gilead.com.

The speakers on todayâs call will be our Chairman and Chief Executive Officer, Daniel OâDay; our Chief Commercial Officer, Johanna Mercier; our Chief Medical Officer, Merdad Parsey; and our Chief Financial Officer, Andrew Dickinson. After that, weâll open the call to Q&A, where the team will be joined by Cindy Perettie, the Executive Vice President of Kite.

Before we get started, let me remind you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot